Nuvectis Pharma, Inc.(NVCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVCT Nuvectis Pharma, Inc.

Market Closed 07-02 16:00:00 EDT

19.57

+0.05

+0.26%

盘后19.31

-0.26-1.32%

19:57 EDT

High20.35	Low19.04	Vol654.53K
Open19.94	D1 Closing19.52	Amplitude6.71%
Mkt Cap519.10M	Tradable Cap302.80M	Total Shares26.53M
T/O12.98M	T/O Rate4.23%	Tradable Shares15.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":19.57,"timestamp":1783022400000,"preClose":19.52,"halted":0,"volume":654527,"hourTrading":{"tag":"盘后","latestPrice":19.3113,"preClose":19.57,"latestTime":"19:57 EDT","volume":1442,"amount":28119.6589,"timestamp":1783036654297,"change":-0.2587,"changeRate":-0.013219,"amplitude":0.013219},"delay":0,"changeRate":0.0025614754098361022,"floatShares":15472700,"shares":26525533,"eps":-1.304517,"marketStatus":"Market Closed","change":0.05,"latestTime":"07-02 16:00:00 EDT","open":19.94,"high":20.35,"low":19.04,"amount":12980438.740695,"amplitude":0.067111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.304517,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":19.52,"preHourTrading":{"tag":"盘前","latestPrice":19.92,"preClose":19.52,"latestTime":"09:27 EDT","volume":468,"amount":9142.050528,"timestamp":1782998870054,"change":0.4,"changeRate":0.020492,"amplitude":0.057351},"postHourTrading":{"tag":"盘后","latestPrice":19.3113,"preClose":19.57,"latestTime":"19:57 EDT","volume":1442,"amount":28119.6589,"timestamp":1783036654297,"change":-0.2587,"changeRate":-0.013219,"amplitude":0.013219},"volumeRatio":0.49815367004505123,"impliedVol":1.7162,"impliedVolPercentile":0.7849},"requestUrl":"/m/hq/s/NVCT","defaultTab":"news","newsList":[{"id":"2648157362","title":"Insiders Make Bold Move as Nuvectis Pharma Leadership Ramps Up Buying Spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2648157362","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648157362?lang=en_us&edition=fundamental","pubTime":"2026-07-02 10:04","pubTimestamp":1782957872,"startTime":"0","endTime":"0","summary":"New insider activity at Nuvectis Pharma ( ($NVCT) ) has taken place on July 1, 2026. Nuvectis Pharma has seen notable insider buying activity, with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insiders-make-bold-move-as-nuvectis-pharma-leadership-ramps-up-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insiders-make-bold-move-as-nuvectis-pharma-leadership-ramps-up-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","SHAP.U","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648540298","title":"Nuvectis Pharma Chairman, CEO Ron Bentsur Buys USD 250,000 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648540298","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648540298?lang=en_us&edition=fundamental","pubTime":"2026-07-02 01:40","pubTimestamp":1782927656,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Chairman, CEO Ron Bentsur buys USD 250,000 common sharesNuvectis Pharma Chairman and CEO Ron Bentsur bought 12,500 common shares at USD 20 each in a public offering.His direct benefici","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL33gW1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Nuvectis Pharma Chairman, CEO Ron Bentsur Buys USD 250,000 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647556528","title":"Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2647556528","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647556528?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:03","pubTimestamp":1782820980,"startTime":"0","endTime":"0","summary":"US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak Q2 results and lowered FY26 guidance. Other stocks also decline in pre-market trading.","market":"hk","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/06/30/Konskie--Poland---August-14--2025-Concen.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/06/30/Konskie--Poland---August-14--2025-Concen.jpg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/06/60182200/concentrix-reports-downbeat-q2-earnings-joins-nuvectis-pharma-vishay-intertechnology-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/06/60182200/concentrix-reports-downbeat-q2-earnings-joins-nuvectis-pharma-vishay-intertechnology-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["VSH","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647258558","title":"Nuvectis Pharma Tumbles on Deep-discounted $100 Mln Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2647258558","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647258558?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:40","pubTimestamp":1782819643,"startTime":"0","endTime":"0","summary":"BUZZ-Nuvectis Pharma tumbles on deep-discounted $100 mln share sale** Shares of Nuvectis PharmaNVCT.Odown 22% to $22.25 before the bell after $100 mln follow-on offering priced** NVCT late Mon sold 5 mln shares at $20, a 30% discount to their record-high close of $28.53** Cantor Fitzgerald sole bookrunner** Fort Lee, New Jersey-based NVCT, which has 26.5 mln shares outstanding, intends to use net offering proceeds to advance programs of NXP100, NXP200, and NXP900 or any future product candidate, among other purposes** On Jun 22, NVCT said itsecured licensing dealwith China's Haisco002653.SZfor experimental drugs NXP100 and NXP200, targeting complement-mediated diseases and cancer to broaden its pipeline** NVCT shares have nearly tripled this month through Mon** All 5 analysts rate the shares  \"buy\" and their median PT is $30, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL6N4320P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0033","BK0028","BK4139","NVCT","BK0188","BK0239","BK0077","002653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647755810","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2647755810","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647755810?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:35","pubTimestamp":1782819325,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics  shares were down 37% in Tuesday premarket activity, following the previous session's 8% gain.GMEX Robotics  stock was down 34% after the company said it would implement a 1-for-9 share consolidation of its Class A and Class B ordinary shares.Universe Pharmaceuticals  shares were down 29% after the previous session's 311% rally.Nuvectis Pharma  stock was down 24% after the company priced a secondary offering of 5 million common shares at $20 per share.Decoy Therapeutics  shares were down 21%, following the earlier session's 74% gain.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UPC","DCOY","BK4200","UNCY","BK4007","BK4539","GMEX","BK4139","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647458985","title":"Nuvectis Pharma Prices 5 Million-share Offering at $20, Raising $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2647458985","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647458985?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:30","pubTimestamp":1782786617,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma prices 5 million-share offering at $20, raising $100 millionNuvectis priced an underwritten public offering of 5,000,000 common shares at USD 20 per share.Gross proceeds expected at US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL80JYZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NVCT","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4139","LU2210150020.SGD","BK4585","BK4588","IE00BN0W2V16.EUR","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647307702","title":"Nuvectis Pharma TBA Spot Secondary; price range $20.00-$22.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2647307702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647307702?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:50","pubTimestamp":1782769811,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald is acting as sole book running manager for the offering. Published first on TheFly – the ultimate source for real-time, market-mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-tba-spot-secondary-price-range-20-00-22-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-tba-spot-secondary-price-range-20-00-22-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304292","title":"Nuvectis Pharma - Lowers Sales Agreement Prospectus Amount to $5 Mln as of June 29, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304292?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:14","pubTimestamp":1782764071,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43115Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647130405","title":"Nuvectis Pharma announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2647130405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647130405?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:05","pubTimestamp":1782763518,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NVCT) announced that it has commenced an underwritten public offering of its common stock. All of the shares to be sold in the off...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647130418","title":"Nuvectis Pharma Launches Underwritten Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2647130418","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647130418?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:01","pubTimestamp":1782763293,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma launches underwritten public offering of common stockNuvectis Pharma commenced an underwritten public offering of common stock, with all shares sold by the company.Underwriters get a 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL5pfWjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014013.SGD","BK4139","NDAQ","BK4588","SG9999014005.SGD","BK4112","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2095319765.USD","NVCT","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304915","title":"Nuvectis Pharma Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304915?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:01","pubTimestamp":1782763260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUABGGQJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646817230","title":"Nuvectis Pharma up over 32%, on Pace for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2646817230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646817230?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:30","pubTimestamp":1782322200,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma, Inc.  is currently at $23.23, up $5.68 or 32.36%--Would be new all-time closing high --On pace for largest percent increase since Feb. 7, 2022, when it rose 144.62%--Currently up 11 consecutive days; up 146.6% over this period--Longest winning streak since Oct. 25, 2024, when it rose for 13 straight trading days--Best 11 day stretch on record --Up 138.26% month-to-date; on pace for best month on record --Up 207.68% year-to-date--Up 200.13% from 52 weeks ago , when it closed at $7.74--Would be a new 52-week closing high--Up 311.15% from its 52-week closing low of $5.65 on Nov. 5, 2025--Traded as high as $23.70; new all-time intraday high --Up 35.04% at today's intraday high; largest intraday percent increase since May 6, 2022, when it rose as much as 35.48%All data as of 1:27:32 PM ETSource: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 24, 2026 13:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBSB","BBLB","SHY","BK4588","ISHG","TBJL","BWZ","IGOV","TLH","BK4139","TLTW","TLTX","SHV","SGOV","TFJL","BBIB","FLGV","IEI","NVCT","BK4585","BWX","TSYW","IEF","TLTI","TLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645890282","title":"Analysts Offer Insights on Healthcare Companies: AdaptHealth (AHCO), Argenx Se (ARGX) and Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645890282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645890282?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:50","pubTimestamp":1782301823,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AdaptHealth (AHCO), Argenx Se (ARGX) and Nuvectis Ph...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adapthealth-ahco-argenx-se-argx-and-nuvectis-pharma-nvct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adapthealth-ahco-argenx-se-argx-and-nuvectis-pharma-nvct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2324357040.USD","BK4139","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0320765992.SGD","AHCO","LU0029874061.USD","LU0128526141.USD","BK4175","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IE0034235188.USD","HCSG","LU0889565916.HKD","BK4588","BK4585","LU1983260115.SGD","XLV","IE00B2B36J28.USD","NVCT","BK4505","LABU","XBI","ARGX","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645348268","title":"Roth MKM Remains a Buy on Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645348268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645348268?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:29","pubTimestamp":1782221391,"startTime":"0","endTime":"0","summary":"Roth MKM analyst maintained a Buy rating on Nuvectis Pharma today and set a price target of $20.00. In a report released today, H.C. Wainwright als...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-nuvectis-pharma-nvct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-nuvectis-pharma-nvct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645885114","title":"Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending","url":"https://stock-news.laohu8.com/highlight/detail?id=2645885114","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645885114?lang=en_us&edition=fundamental","pubTime":"2026-06-23 14:30","pubTimestamp":1782196200,"startTime":"0","endTime":"0","summary":"NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/06/23/Trade-And-Finance-Concept--Dark-Forex-Ch.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/06/23/Trade-And-Finance-Concept--Dark-Forex-Ch.jpg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/06/60034390/nuvectis-pharma-jumps-20-to-52-week-high-heres-why-nvct-stock-is-trending","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/06/60034390/nuvectis-pharma-jumps-20-to-52-week-high-heres-why-nvct-stock-is-trending","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["NVCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152002965","title":"Haisco Pharmaceutical Group Enters Licensing Agreement with Nuvectis for Two Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1152002965","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152002965?lang=en_us&edition=fundamental","pubTime":"2026-06-23 08:50","pubTimestamp":1782175828,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical Group Co.,Ltd. (SHE: 002653) has announced the signing of an exclusive licensing agreement with U.S.-based Nuvectis Pharma, Inc. Under the terms of the deal, Nuvectis has been...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","BK0033","BK0077","002653","NVCT","BK4139","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645751071","title":"Nuvectis Pharma price target raised to $22 from $18 at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2645751071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645751071?lang=en_us&edition=fundamental","pubTime":"2026-06-23 01:42","pubTimestamp":1782150135,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Christopher Liu raised the firm’s price target on Nuvectis Pharma (NVCT) to $22 from $18 and keeps a Buy rating on the shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-price-target-raised-to-22-from-18-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-price-target-raised-to-22-from-18-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCID","NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645076344","title":"Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2645076344","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645076344?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:40","pubTimestamp":1782142800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NVCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 11:40 ET (15:40 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645075788","title":"Nuvectis Pharma price target raised to $39 from $13 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645075788?lang=en_us&edition=fundamental","pubTime":"2026-06-22 23:06","pubTimestamp":1782140787,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Nuvectis Pharma (NVCT) to $39 from $13 and keeps a Buy rating on the shares. The firm says the co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-price-target-raised-to-39-from-13-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-price-target-raised-to-39-from-13-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645222920","title":"Nuvectis Lands Major Haisco Deal for Two Potentially Best-in-Class Compounds in Multi-Billion-Dollar Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2645222920","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645222920?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:30","pubTimestamp":1782131409,"startTime":"0","endTime":"0","summary":"WSW, NY, June 22nd, 2026, FinanceWire Nuvectis Pharma (NASDAQ:NVCT) opened the trading week with a transaction that transforms the small-cap precis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/nuvectis-lands-major-haisco-deal-for-two-potentially-best-in-class-compounds-in-multi-billion-dollar-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/nuvectis-lands-major-haisco-deal-for-two-potentially-best-in-class-compounds-in-multi-billion-dollar-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYW","QDTE","QQQE","TQQQ","QQQY","MNQmain","QYLG","GPIQ","BK4139","NDX","ONEQ","QID","QQQ","JEPQ","NVCT","QLD","QQQM","NQmain","TECS","TQQY","NVIW.SI","FTEC","PSQ","SQQQ",".IXIC","QQQA","QQQJ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvectis.com","stockEarnings":[{"period":"1week","weight":-0.2978},{"period":"1month","weight":1.0578},{"period":"3month","weight":1.5886},{"period":"6month","weight":1.2996},{"period":"1year","weight":1.6024},{"period":"ytd","weight":1.5921}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company's lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trials for the treatment of patients with platinum-resistant, ARID1a-mutated ovarian carcinoma. It is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trails that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.130119},{"month":2,"riseRate":0.75,"avgChangeRate":0.147062},{"month":3,"riseRate":0.6,"avgChangeRate":0.077847},{"month":4,"riseRate":0.8,"avgChangeRate":0.055849},{"month":5,"riseRate":0.8,"avgChangeRate":0.192364},{"month":6,"riseRate":0.2,"avgChangeRate":0.054549},{"month":7,"riseRate":0.4,"avgChangeRate":-0.067092},{"month":8,"riseRate":0.5,"avgChangeRate":-0.005612},{"month":9,"riseRate":0,"avgChangeRate":-0.100626},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011793},{"month":11,"riseRate":0.25,"avgChangeRate":-0.090389},{"month":12,"riseRate":0.75,"avgChangeRate":0.071233}],"exchange":"NASDAQ","name":"Nuvectis Pharma, Inc.","nameEN":"Nuvectis Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvectis Pharma, Inc.(NVCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvectis Pharma, Inc.(NVCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvectis Pharma, Inc.,NVCT,Nuvectis Pharma, Inc.股票,Nuvectis Pharma, Inc.股票老虎,Nuvectis Pharma, Inc.股票老虎国际,Nuvectis Pharma, Inc.行情,Nuvectis Pharma, Inc.股票行情,Nuvectis Pharma, Inc.股价,Nuvectis Pharma, Inc.股市,Nuvectis Pharma, Inc.股票价格,Nuvectis Pharma, Inc.股票交易,Nuvectis Pharma, Inc.股票购买,Nuvectis Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvectis Pharma, Inc.(NVCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvectis Pharma, Inc.(NVCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}